Name: Pharmacists, pharmaceutical manufacturers, and conflicts of interest
Creator: David Banks
Keywords: 03 medical and health sciences, 0302 clinical medicine, Drug Industry, Conflict of Interest, Humans, Ethics, Pharmacy, United States, 3. Good health

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2005 English Publisher:Oxford University Press (OUP)Journal:American Journal of Health-System Pharmacy, volume 62, pages 1,827-1,832 (issn: 1079-2082, eissn: 1535-2900,

Authors: David Banks;

doi: 10.2146/ajhp040504

pmid: 16120744

Pharmacists, pharmaceutical manufacturers, and conflicts of interest

- Summary
- Subjects
- Metrics

Abstract

Conflicts of interest (COIs) represent an expanding challenge for pharmacists as their therapeutic influence grows. Many potential COI relationships involve pharmaceutical manufacturers, who have characterized pharmacists as “a growing force to be reckoned with.”[1][1] The expanded influence of

Related Organizations

United States Food and Drug Administration
United States

Keywords

Drug Industry, Conflict of Interest, Humans, Ethics, Pharmacy, United States

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average